Multidimensional Clinical Challenges in a Female with Chronic Epilepsy on Phenytoin: A Case Report
DOI:
https://doi.org/10.12928/admj.v6i2.14276Keywords:
epilepsy, phenytoin, sexual dysfunction, clobazam, comprehensive managementAbstract
Epilepsy is a long-standing neurological disorder defined by recurrent, unprovoked seizures, affecting more than 50 million individuals globally and influencing physical, mental, and social aspects of life. Continuous administration of antiepileptic drugs (AEDs) such as phenytoin is a common therapeutic strategy; however, prolonged use may result in adverse effects that complicate treatment. This case report describes a 40-year-old woman with epilepsy since the age of four, presenting with recurrent seizures, impaired memory, headaches, and sexual dysfunction. Her most recent event was an absence seizure accompanied by upward eye deviation and tongue biting. Electroencephalography (EEG) demonstrated generalized spike-and-wave patterns. The patient was treated with phenytoin and folic acid, with the recent addition of clobazam, leading to favorable outcomes, including reduced seizure frequency, improved sleep, and diminished anxiety and dizziness. A persistent reduction in libido, first noted during adolescence, was suspected to be associated with long-term phenytoin use. Additionally, dental problems such as caries and tooth impaction were believed to worsen headache intensity. This case emphasizes the need for a comprehensive approach to epilepsy care, considering psychological conditions, cognitive impairment, and oral health. Prompt recognition of AED-related side effects and individualized treatment planning are essential to optimize patient outcomes.
References
Weinstein S. Seizures and epilepsy: An overview. Epilepsy: The Intersection of Neurosciences, Biology, Mathematics, Engineering, and Physics. 2016;65–77.
Srivastav Y, Prajapati A, Agrahari P, Kumar M. Review of the Epilepsy, Including Its Causes, Symptoms, Biomarkers, and Management. Asian Journal of Research in Medical and Pharmaceutical Sciences. 2023;12(4):64–84.
Aggression A, Agitation B, Anger C, Hostility D, Impulsivity E, Irritability F. Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review s. Pharmacol Rev. 2016;68:563–602.
Kanner AM. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Epilepsy and Behavior [Internet]. 2016;61:282–6. Available from: http://dx.doi.org/10.1016/j.yebeh.2016.03.022
Mulaf M. The pharmacological management of psychiatric comorbidities in patients with epilepsy. Pharmacol Res [Internet]. 2016;107:147–53. Available from: http://dx.doi.org/10.1016/j.phrs.2016.03.022
Potnis VV, Albhar KG, Nanaware PA, Pote VS. A Review on Epilepsy and its Management. Journal of Drug Delivery and Therapeutics. 2020;10(3):273–9.
Samami M, Najar-Karimi F, Eghbali BB, Sanati AH, Rad AH. Oral and dental health status in patients with chronic headache. BMC Oral Health. 2024;24(1).
Badea M, Muresanu DF. Dental Care for Patients With Neurological Disorders. Romanian Journal of Neurology. 2008;VII(1):1–4.
Thompson P, Huppert FA, Trimble M. Phenytoin and cognitive function: Effects on normal volunteers and implications for epilepsy. British Journal of Clinical Psychology. 1981;20(3):155–62.
Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: Challenges and solutions. Neuropsychiatr Dis Treat. 2016;12:467–85.
Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB. A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management. Brain Sci. 2023;13(9).
Gilliam F, Hecimovic H, Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy and Behavior. 2003;4(SUPPL. 4):26–30.
Kwan P, Brodie MJ. Early Identification of Refractory Epilepsy. N Engl J Med. 2000;342(5):314–20.
Potnis VV, Albhar KG, Nanaware PA, Pote VS. A Review on Epilepsy and its Management. Journal of Drug Delivery and Therapeutics. 2020;10(3):273–9.
Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: Excitability and inflammation. Trends Neurosci [Internet]. 2013;36(3):174–84. Available from: http://dx.doi.org/10.1016/j.tins.2012.11.008
Sumadewi KT, Harkitasari S, Tjandra DC. Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptologica [Internet]. 2023;5(1). Available from: https://doi.org/10.1186/s42494-023-00137-0
Foldvary-Schaefer N, Grigg-Damberger M. Sleep and epilepsy: What we know, don’t know, and need to know. Journal of Clinical Neurophysiology. 2006;23(1):4–20.
Manole AM, Sirbu CA, Mititelu MR, Vasiliu O, Lorusso L, Sirbu OM, et al. State of the Art and Challenges in Epilepsy—A Narrative Review. J Pers Med. 2023;13(4).
Michaelis R, Tang V, Wagner JL, Modi AC, Lafrance WC, Goldstein LH, et al. Psychological treatments for people with epilepsy. Cochrane Database of Systematic Reviews. 2017;2017(10).
Spanos S, Hutchinson K, Ryder T, Rapport F, Goodwin N, Zurynski Y. Integrated Care in Epilepsy Management: A Scoping Review of the Models and Components of Health and Social Care Delivery. Int J Integr Care. 2024;24(1):1–16.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Syafira Laila Nurulita, Rusdi Lamsudin
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal. Please also carefully read Ahmad Dahlan Medical Journal posting Your Article Policy.
- That it is not under consideration for publication elsewhere.
- That its publication has been approved by all the author(s) and by the responsible authorities - tacitly or explicitly - of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with Ahmad Dahlan Medical Journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
